Skip to main content
PMC home page
Gut logoLink to Gut
. 1997 Jun;40(6):775–781. doi: 10.1136/gut.40.6.775

Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis.

J K Marshall 1, E J Irvine 1
PMCID: PMC1027203  PMID: 9245932

Abstract

BACKGROUND: Clear strategies to optimise the use of corticosteroids in ulcerative colitis are lacking. AIM: A meta-analysis was undertaken to examine critically the role of rectal corticosteroids in the management of active distal ulcerative colitis. METHODS: All reported randomised controlled trials were retrieved by searching the Medline and EMBASE databases and the bibliographies of relevant studies. Trials which met inclusion criteria were assessed for scientific rigour. Data were extracted by two independent observers according to predetermined criteria. RESULTS: Of 83 trials retrieved, 33 met inclusion criteria. Pooled odds ratios (POR) showed conventional rectal corticosteroids and rectal budesonide to be clearly superior to placebo. In seven trials, rectal 5-aminosalicylic acid (5-ASA) was significantly better than conventional rectal corticosteroids for inducing remission of symptoms, endoscopy, and histology with POR of 2.42 (95% confidence interval (CI) 1.72-3.41), 1.89 (95% CI 1.29-2.76), and 2.03 (95% CI 1.28-3.20), respectively. Rectal budesonide was of comparable efficacy to conventional corticosteroids but produced less endogenous cortisol suppression. Side effects, although inconsistently reported, were generally minor. A cost comparison of rectal preparations showed 5-ASA to be less expensive than corticosteroids. CONCLUSIONS: Rectal 5-ASA is superior to rectal corticosteroids in the management of distal ulcerative colitis.

Full text

PDF
776

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Betamethasone 17-valerate and prednisolone 21-phosphate retention enemata in proctocolitis. A multicentre trial. Br Med J. 1971 Jul 10;3(5766):84–86. [PMC free article] [PubMed] [Google Scholar]
  2. Bianchi Porro G., Ardizzone S., Petrillo M., Fasoli A., Molteni P., Imbesi V. Low Pentasa dosage versus hydrocortisone in the topical treatment of active ulcerative colitis: a randomized, double-blind study. Am J Gastroenterol. 1995 May;90(5):736–739. [PubMed] [Google Scholar]
  3. Bianchi Porro G., Ardizzone S., Petrillo M., Fasoli A., Molteni P., Imbesi V. Low Pentasa dosage versus hydrocortisone in the topical treatment of active ulcerative colitis: a randomized, double-blind study. Am J Gastroenterol. 1995 May;90(5):736–739. [PubMed] [Google Scholar]
  4. Campieri M., Corbelli C., Gionchetti P., Brignola C., Belluzzi A., Di Febo G., Zagni P., Brunetti G., Miglioli M., Barbara L. Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis. Dig Dis Sci. 1992 Dec;37(12):1890–1897. doi: 10.1007/BF01308084. [DOI] [PubMed] [Google Scholar]
  5. Campieri M., Lanfranchi G. A., Bazzocchi G., Brignola C., Sarti F., Franzin G., Battocchia A., Labo G., Dal Monte P. R. Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas. Lancet. 1981 Aug 8;2(8241):270–271. doi: 10.1016/s0140-6736(81)90523-7. [DOI] [PubMed] [Google Scholar]
  6. Campieri M., Lanfranchi G. A., Brignola C., Bazzocchi G., Gionchetti P., Minguzzi M. R., Cappello I. P., Corbelli C., Boschi S. Retrograde spread of 5-aminosalicylic acid enemas in patients with active ulcerative colitis. Dis Colon Rectum. 1986 Feb;29(2):108–110. doi: 10.1007/BF02555391. [DOI] [PubMed] [Google Scholar]
  7. Cann P. A., Holdsworth C. D. Systemic absorption from hydrocortisone foam enema in ulcerative colitis. Lancet. 1987 Apr 18;1(8538):922–923. doi: 10.1016/s0140-6736(87)92900-x. [DOI] [PubMed] [Google Scholar]
  8. Chapman N. J., Brown M. L., Phillips S. F., Tremaine W. J., Schroeder K. W., Dewanjee M. K., Zinsmeister A. R. Distribution of mesalamine enemas in patients with active distal ulcerative colitis. Mayo Clin Proc. 1992 Mar;67(3):245–248. doi: 10.1016/s0025-6196(12)60100-1. [DOI] [PubMed] [Google Scholar]
  9. Cobden I., al-Mardini H., Zaitoun A., Record C. O. Is topical therapy necessary in acute distal colitis? Double-blind comparison of high-dose oral mesalazine versus steroid enemas in the treatment of active distal ulcerative colitis. Aliment Pharmacol Ther. 1991 Oct;5(5):513–522. doi: 10.1111/j.1365-2036.1991.tb00520.x. [DOI] [PubMed] [Google Scholar]
  10. Danielsson A., Hellers G., Lyrenäs E., Löfberg R., Nilsson A., Olsson O., Olsson S. A., Persson T., Salde L., Naesdal J. A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Scand J Gastroenterol. 1987 Oct;22(8):987–992. doi: 10.3109/00365528708991947. [DOI] [PubMed] [Google Scholar]
  11. Danielsson A., Löfberg R., Persson T., Salde L., Schiöler R., Suhr O., Willén R. A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis. Scand J Gastroenterol. 1992;27(1):9–12. doi: 10.3109/00365529209011158. [DOI] [PubMed] [Google Scholar]
  12. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 Sep;7(3):177–188. doi: 10.1016/0197-2456(86)90046-2. [DOI] [PubMed] [Google Scholar]
  13. Farmer R. G., Schumacher O. P. Treatment of ulcerative colitis with hydrocrotisone enemas: relationship of hydrocortisone absorption, adrenal suppression, and clinical response. Dis Colon Rectum. 1970 Sep-Oct;13(5):355–361. doi: 10.1007/BF02616754. [DOI] [PubMed] [Google Scholar]
  14. Farthing M. J., Rutland M. D., Clark M. L. Retrograde spread of hydrocortisone containing foam given intrarectally in ulcerative colitis. Br Med J. 1979 Oct 6;2(6194):822–824. doi: 10.1136/bmj.2.6194.822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Farup P. G., Hovde O., Halvorsen F. A., Raknerud N., Brodin U. Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens. Scand J Gastroenterol. 1995 Feb;30(2):164–170. doi: 10.3109/00365529509093256. [DOI] [PubMed] [Google Scholar]
  16. Friedman L. S., Richter J. M., Kirkham S. E., DeMonaco H. J., May R. J. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial. Am J Gastroenterol. 1986 Jun;81(6):412–418. [PubMed] [Google Scholar]
  17. Grace R. H., Gent A. E., Hellier M. D. Comparative trial of sodium cromoglycate enemas with prednisolone enemas in the treatment of ulcerative colitis. Gut. 1987 Jan;28(1):88–92. doi: 10.1136/gut.28.1.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Halpern Z., Sold O., Baratz M., Konikoff F., Halak A., Gilat T. A controlled trial of beclomethasone versus betamethasone enemas in distal ulcerative colitis. J Clin Gastroenterol. 1991 Feb;13(1):38–41. doi: 10.1097/00004836-199102000-00009. [DOI] [PubMed] [Google Scholar]
  19. Hamilton I., Pinder I. F., Dickinson R. J., Ruddell W. S., Dixon M. F., Axon A. T. A comparison of prednisolone enemas with low-dose oral prednisolone in the treatment of acute distal ulcerative colitis. Dis Colon Rectum. 1984 Nov;27(11):701–702. doi: 10.1007/BF02554591. [DOI] [PubMed] [Google Scholar]
  20. Jay M., Beihn R. M., Digenis G. A., Deland F. H., Caldwell L., Mlodozeniec A. R. Disposition of radiolabelled suppositories in humans. J Pharm Pharmacol. 1985 Apr;37(4):266–268. doi: 10.1111/j.2042-7158.1985.tb05058.x. [DOI] [PubMed] [Google Scholar]
  21. Jay M., Digenis G. A., Foster T. S., Antonow D. R. Retrograde spreading of hydrocortisone enema in inflammatory bowel disease. Dig Dis Sci. 1986 Feb;31(2):139–144. doi: 10.1007/BF01300698. [DOI] [PubMed] [Google Scholar]
  22. Kruis W., Büll U., Eisenburg J., Paumgartner G. Retrograde colonic spread of sulphasalazine enemas. Scand J Gastroenterol. 1982 Oct;17(7):933–938. doi: 10.3109/00365528209181117. [DOI] [PubMed] [Google Scholar]
  23. LENNARD-JONES J. E., BARON J. H., CONNELL A. M., JONES F. A. A double blind controlled trial of prednisolone-21-phosphate suppositories in the treatment of idiopathic proctitis. Gut. 1962 Sep;3:207–210. doi: 10.1136/gut.3.3.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. LENNARD-JONES J. E., LONGMORE A. J., NEWELL A. C., WILSON C. W., JONES F. A. An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis. Gut. 1960 Sep;1:217–222. doi: 10.1136/gut.1.3.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lee D. A., Taylor G. M., James V. H., Walker G. Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone-21-phosphate as a retention enema. Gut. 1979 May;20(5):349–355. doi: 10.1136/gut.20.5.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lee F. I., Jewell D. P., Mani V., Keighley M. R., Kingston R. D., Record C. O., Grace R. H., Daniels S., Patterson J., Smith K. A randomised trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis. Gut. 1996 Feb;38(2):229–233. doi: 10.1136/gut.38.2.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Luman W., Gray R. S., Pendek R., Palmer K. R. Prednisolone metasulphobenzoate foam retention enemas suppress the hypothalamo-pituitary-adrenal axis. Aliment Pharmacol Ther. 1994 Apr;8(2):255–258. doi: 10.1111/j.1365-2036.1994.tb00284.x. [DOI] [PubMed] [Google Scholar]
  28. Lémann M., Galian A., Rutgeerts P., Van Heuverzwijn R., Cortot A., Viteau J. M., Elewaut A., Belaiche J., Froguel E., Modigliani R. Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis. Aliment Pharmacol Ther. 1995 Oct;9(5):557–562. doi: 10.1111/j.1365-2036.1995.tb00421.x. [DOI] [PubMed] [Google Scholar]
  29. Löfberg R., Ostergaard Thomsen O., Langholz E., Schiöler R., Danielsson A., Suhr O., Graffner H., Påhlman L., Matzen P., Møller-Petersen J. F. Budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Aliment Pharmacol Ther. 1994 Dec;8(6):623–629. doi: 10.1111/j.1365-2036.1994.tb00340.x. [DOI] [PubMed] [Google Scholar]
  30. Löfberg R., Ostergaard Thomsen O., Langholz E., Schiöler R., Danielsson A., Suhr O., Graffner H., Påhlman L., Matzen P., Møller-Petersen J. F. Budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Aliment Pharmacol Ther. 1994 Dec;8(6):623–629. doi: 10.1111/j.1365-2036.1994.tb00340.x. [DOI] [PubMed] [Google Scholar]
  31. Marshall J. K., Irvine E. J. Rectal aminosalicylate therapy for distal ulcerative colitis: a meta-analysis. Aliment Pharmacol Ther. 1995 Jun;9(3):293–300. doi: 10.1111/j.1365-2036.1995.tb00384.x. [DOI] [PubMed] [Google Scholar]
  32. Meyers S., Janowitz H. D. The "natural history" of ulcerative colitis: an analysis of the placebo response. J Clin Gastroenterol. 1989 Feb;11(1):33–37. doi: 10.1097/00004836-198902000-00008. [DOI] [PubMed] [Google Scholar]
  33. Mulder C. J., Endert E., van der Heide H., Houthoff H. J., Wiersinga W., Wiltink E. H., Tytgat G. N. Comparison of beclomethasone dipropionate (2 and 3 mg) and prednisolone sodium phosphate enemas (30 mg) in the treatment of ulcerative proctitis. An adrenocortical approach. Neth J Med. 1989 Aug;35(1-2):18–24. [PubMed] [Google Scholar]
  34. Mulder C. J., Tytgat G. N. Review article: topical corticosteroids in inflammatory bowel disease. Aliment Pharmacol Ther. 1993 Apr;7(2):125–130. doi: 10.1111/j.1365-2036.1993.tb00080.x. [DOI] [PubMed] [Google Scholar]
  35. Mulder C. J., Tytgat G. N., Wiltink E. H., Houthoff H. J. Comparison of 5-aminosalicylic acid (3 g) and prednisolone phosphate sodium enemas (30 mg) in the treatment of distal ulcerative colitis. A prospective, randomized, double-blind trial. Scand J Gastroenterol. 1988 Oct;23(8):1005–1008. doi: 10.3109/00365528809090161. [DOI] [PubMed] [Google Scholar]
  36. Mulder C. J., Tytgat G. N., Wiltink E. H., Houthoff H. J. Comparison of 5-aminosalicylic acid (3 g) and prednisolone phosphate sodium enemas (30 mg) in the treatment of distal ulcerative colitis. A prospective, randomized, double-blind trial. Scand J Gastroenterol. 1988 Oct;23(8):1005–1008. doi: 10.3109/00365528809090161. [DOI] [PubMed] [Google Scholar]
  37. Nyman-Pantelidis M., Nilsson A., Wagner Z. G., Borgå O. Pharmacokinetics and retrograde colonic spread of budesonide enemas in patients with distal ulcerative colitis. Aliment Pharmacol Ther. 1994 Dec;8(6):617–622. doi: 10.1111/j.1365-2036.1994.tb00339.x. [DOI] [PubMed] [Google Scholar]
  38. O'Donnell L. J., Arvind A. S., Hoang P., Cameron D., Talbot I. C., Jewell D. P., Lennard-Jones J. E., Farthing M. J. Double blind, controlled trial of 4-aminosalicylic acid and prednisolone enemas in distal ulcerative colitis. Gut. 1992 Jul;33(7):947–949. doi: 10.1136/gut.33.7.947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Powell-Tuck J., Lennard-Jones J. E., May C. S., Wilson C. G., Paterson J. W. Plasma prednisolone levels after administration of prednisolone-21-phosphate as a retention enema in colitis. Br Med J. 1976 Jan 24;1(6003):193–195. doi: 10.1136/bmj.1.6003.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Powell-Tuck J., Lennard-Jones J. E., May C. S., Wilson C. G., Paterson J. W. Plasma prednisolone levels after administration of prednisolone-21-phosphate as a retention enema in colitis. Br Med J. 1976 Jan 24;1(6003):193–195. doi: 10.1136/bmj.1.6003.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Riley S. A., Gupta I., Mani V. A comparison of sucralfate and prednisolone enemas in the treatment of active distal ulcerative colitis. Scand J Gastroenterol. 1989 Oct;24(8):1014–1018. doi: 10.3109/00365528909089249. [DOI] [PubMed] [Google Scholar]
  42. Riley S. A., Mani V., Goodman M. J., Dutt S., Herd M. E. Microscopic activity in ulcerative colitis: what does it mean? Gut. 1991 Feb;32(2):174–178. doi: 10.1136/gut.32.2.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Ruddell W. S., Dickinson R. J., Dixon M. F., Axon A. T. Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: comparison of hydrocortisone enemas and rectal hydrocortisone foam. Gut. 1980 Oct;21(10):885–889. doi: 10.1136/gut.21.10.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sharma M. P., Duphare H. V., Dasarathy S. A prospective randomized double blind trial comparing prednisolone and 4-aminosalicylic acid enemas in acute distal ulcerative colitis. J Gastroenterol Hepatol. 1992 Mar-Apr;7(2):173–177. doi: 10.1111/j.1440-1746.1992.tb00957.x. [DOI] [PubMed] [Google Scholar]
  45. Spencer C. M., McTavish D. Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease. Drugs. 1995 Nov;50(5):854–872. doi: 10.2165/00003495-199550050-00006. [DOI] [PubMed] [Google Scholar]
  46. Swarbrick E. T., Loose H., Lennard-Jones J. E. Enema volume as an important factor in successful topical corticosteroid treatment of colitis. Proc R Soc Med. 1974 Aug;67(8):753–754. [PMC free article] [PubMed] [Google Scholar]
  47. TRUELOVE S. C. Treatment of ulcerative colitis with local hydrocortisone. Br Med J. 1956 Dec 1;2(5004):1267–1272. doi: 10.1136/bmj.2.5004.1267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. TRUELOVE S. C., WITTS L. J. Cortisone in ulcerative colitis; preliminary report on a therapeutic trial. Br Med J. 1954 Aug 14;2(4884):375–378. doi: 10.1136/bmj.2.4884.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Tarpila S., Turunen U., Seppälä K., Aukee S., Pikkarainen P., Elomaa I., Karvonen A. L., Käriäinen I., Sipponen P., Toivanen E. Budesonide enema in active haemorrhagic proctitis--a controlled trial against hydrocortisone foam enema. Aliment Pharmacol Ther. 1994 Dec;8(6):591–595. doi: 10.1111/j.1365-2036.1994.tb00335.x. [DOI] [PubMed] [Google Scholar]
  50. Tiel-van Buul M. M., Mulder C. J., van Royen E. A., Wiltink E. H., Tytgat G. N. Retrograde spread of mesalazine (5-aminosalicylic acid)-containing enema in patients with ulcerative colitis. Clin Pharmacokinet. 1991 Mar;20(3):247–251. doi: 10.2165/00003088-199120030-00006. [DOI] [PubMed] [Google Scholar]
  51. Topical 5-aminosalicylic acid versus prednisolone in ulcerative proctosigmoiditis. A randomized, double-blind multicenter trial. Danish 5-ASA Group. Dig Dis Sci. 1987 Jun;32(6):598–602. [PubMed] [Google Scholar]
  52. WATKINSON G. Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate sodium; a controlled trial employing restricted sequential analysis. Br Med J. 1958 Nov 1;2(5104):1077–1082. doi: 10.1136/bmj.2.5104.1077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Wilding I. R., Kenyon C. J., Chauhan S., Hooper G., Marshall S., McCracken J. S., Staab H. J., Armbrecht J. Colonic spreading of a non-chlorofluorocarbon mesalazine rectal foam enema in patients with quiescent ulcerative colitis. Aliment Pharmacol Ther. 1995 Apr;9(2):161–166. doi: 10.1111/j.1365-2036.1995.tb00365.x. [DOI] [PubMed] [Google Scholar]
  54. Williams C. N., Haber G., Aquino J. A. Double-blind, placebo-controlled evaluation of 5-ASA suppositories in active distal proctitis and measurement of extent of spread using 99mTc-labeled 5-ASA suppositories. Dig Dis Sci. 1987 Dec;32(12 Suppl):71S–75S. doi: 10.1007/BF01312468. [DOI] [PubMed] [Google Scholar]
  55. van Bodegraven A. A., Boer R. O., Lourens J., Tuynman H. A., Sindram J. W. Distribution of mesalazine enemas in active and quiescent ulcerative colitis. Aliment Pharmacol Ther. 1996 Jun;10(3):327–332. doi: 10.1111/j.0953-0673.1996.00327.x. [DOI] [PubMed] [Google Scholar]
  56. van der Heide H., van den Brandt-Gradel V., Tytgat G. N., Endert E., Wiltink E. H., Schipper M. E., Dekker W. Comparison of beclomethasone dipropionate and prednisolone 21-phosphate enemas in the treatment of ulcerative proctitis. J Clin Gastroenterol. 1988 Apr;10(2):169–172. doi: 10.1097/00004836-198804000-00013. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES